A Deadline is coming up on February 10, 2023 in the lawsuit for certain investors in Twist Bioscience Corporation (NASDAQ: TWST).
San Diego, CA -- (SBWIRE) -- 01/31/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 10, 2023 in the lawsuit filed for certain investors of Twist Bioscience Corporation (NASDAQ: TWST).
Investors who purchased shares of Twist Bioscience Corporation (NASDAQ: TWST) have certain options and there are strict and short deadlines running. Deadline: February 10, 2023. NASDAQ: TWST stockholders should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Twist Bioscience Corporation (NASDAQ: TWST) common shares between December 13, 2019, and November 14, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 13, 2019, and November 14, 2022, the Defendants repeatedly assured investors that the company possessed innovative proprietary technology relating to its synthetic DNA products that positioned Twist for significant future growth, that the Defendants claimed that Twist had already achieved substantial growth between December 13, 2019, and November 14, 2022, growing from a customer base of approximately 1,300 diagnostic companies, hospitals, research institutions, and others at the end of fiscal year 2019, to approximately 2,900 customers at the end of fiscal year 2021, and that as alleged in the report by Scorpion Capital, Defendants overstated the commercial viability of Twist's synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company's true financial condition and prospects, and that as a result of Defendants' wrongful acts and omissions, and the significant decline in the market value of Twist's common stock, investors between December 13, 2019, and November 14, 2022 have suffered significant damages.
Those who purchased shares of Twist Bioscience Corporation (NASDAQ: TWST) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.